United Financial Planning Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

United Financial Planning Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.95K	Buy	+33	New	+$7.23K	﹤0.01%	288

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

United Financial Planning Group's JAZZ Position: Q2 2026 in Review

United Financial Planning Group opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2026: 33 shares worth $7.95K. The stake represents ﹤0.01% of the portfolio and ranks #288 among its holdings.

641 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

United Financial Planning Group held 33 shares of Jazz Pharmaceuticals worth $7.95K as of Q2 2026.
Jazz Pharmaceuticals was a new United Financial Planning Group position in Q2 2026.
Jazz Pharmaceuticals made up ﹤0.01% of United Financial Planning Group's portfolio in Q2 2026, its #288 holding.
641 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on United Financial Planning Group's 13F filing for Q2 2026, filed 6 Aug 2026.